Cytogenetic Systems Market
Cytogenetic Systems Market Global Industry Assessment & Forecast
#
Pages:
180
2021
Nov - 2021
VMR-2021-0171
Segments Covered
By
Product Flow cytometry, Fluorescence In Situ Hybridization (FISH), Multiplex- Fluorescence In Situ Hybridization (M-FISH), Comparative Genomic Hybridization (CGH)
-
By
Application Genetic Disorders, Neoplastic Diseases, Personalized Medicine, Others
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
2.54 Billion |
 Revenue 2028:
|
4.45 Billion |
 Revenue CAGR
(2021 - 2028): |
8.2 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
The report delivers an acute breakdown of the market based on various segments such as Product, Application, , and region. The report includes market size and forecast for each segment by region/country for the years 2016–2028. Moreover, it also covers a thorough analysis of growth factors and opportunities impacting segmental growth.
On the basis of Product, the market is divided into Flow cytometry, Fluorescence In Situ Hybridization (FISH), Multiplex- Fluorescence In Situ Hybridization (M-FISH), Comparative Genomic Hybridization (CGH). Flow cytometry dominated the global Cytogenetic Systems market in 2020 and is projected to witness the same trend during the forecast period.
Based on Application, the market is segmented into Genetic Disorders, Neoplastic Diseases, Personalized Medicine, Others. Genetic Disorders accounted for the highest market share and is expected to grow at a significant CAGR from 2021 to 2028.
Global Cytogenetic Systems Market: Product Segment Analysis
-
- Flow cytometry
- Fluorescence In Situ Hybridization (FISH)
- Multiplex- Fluorescence In Situ Hybridization (M-FISH)
- Comparative Genomic Hybridization (CGH)
Global Cytogenetic Systems Market: Application Segment Analysis
-
- Genetic Disorders
- Neoplastic Diseases
- Personalized Medicine
- Others
FAQ
Frequently Asked Question
What is the global demand for Cytogenetic Systems in terms of revenue?
-
The global Cytogenetic Systems valued at 2.54 Billion in 2020 and is expected to reach 4.45 Billion in 2028 growing at a CAGR of 8.2%.
Which are the prominent players in the market?
-
The prominent players in the market are ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.2% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Cytogenetic Systems include
- Increasing demand of early diagnosis of serious diseases which are life threatening like cancer and examination of disorders owing to chromosomal anomalies in emerging embryos are the main determinants for the growth of global Cytogenetic Systems market.
- Growth of population pool especially geriatric population, increasing exposure to harmful ultraviolet rays and chemicals, rise in numbers of people adopting bad habits like drinking and smoking and the sedentary lifestyle is driving the market growth.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cytogenetic Systems in 2020.
